IRINOTECAN HYDROCHLORIDE (Camptosar) Nursing Considerations

What is the generic name?

IRINOTECAN HYDROCHLORIDE

What is the Trade Name for IRINOTECAN HYDROCHLORIDE?

Camptosar

What are the Indications for IRINOTECAN HYDROCHLORIDE?

• 1 INDICATIONS AND USAGE CAMPTOSAR is indicated as a component of first-line therapy in combination with 5-fluorouracil (5-FU) and leucovorin (LV) for patients with metastatic carcinoma of the colon or rectum. CAMPTOSAR is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. CAMPTOSAR is a topoisomerase inhibitor indicated for: First-line therapy in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum. ( 1 ) Patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. ( 1 )

References: https://open.fda.gov/